These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28361200)

  • 1. Utilization of Liver Microsomes to Estimate Hepatic Intrinsic Clearance of Monoamine Oxidase Substrate Drugs in Humans.
    Masuo Y; Nagamori S; Hasegawa A; Hayashi K; Isozumi N; Nakamichi N; Kanai Y; Kato Y
    Pharm Res; 2017 Jun; 34(6):1233-1243. PubMed ID: 28361200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-in vivo correlation for intrinsic clearance for CP-409,092 and sumatriptan: a case study to predict the in vivo clearance for compounds metabolized by monoamine oxidase.
    Kamel A; Colizza K; Gunduz M; Harriman S; Obach RS
    Xenobiotica; 2012 Apr; 42(4):355-62. PubMed ID: 22106962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of sumatriptan revisited.
    Pöstges T; Lehr M
    Pharmacol Res Perspect; 2023 Feb; 11(1):e01051. PubMed ID: 36655303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN; LeDuc BW; Khan AA
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.
    Iwasa T; Sano H; Sugiura A; Uchiyama N; Hara K; Okochi H; Nakagawa K; Yasumori T; Ishizaki T
    Br J Clin Pharmacol; 2003 Nov; 56(5):537-44. PubMed ID: 14651728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
    Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
    Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Morita K; Kato M; Kudo T; Ito K
    Xenobiotica; 2020 Sep; 50(9):1064-1075. PubMed ID: 32125203
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of in vivo carbamazepine 10,11-epoxidation from in vitro metabolic studies with human liver microsomes: importance of its sigmoidal kinetics.
    Sakamoto M; Itoh T; Fujiwara R
    Biol Pharm Bull; 2013; 36(12):1959-63. PubMed ID: 24292054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver.
    Dixon CM; Park GR; Tarbit MH
    Biochem Pharmacol; 1994 Mar; 47(7):1253-7. PubMed ID: 8161354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Disconnect in Intrinsic Clearance Determined in Human Hepatocytes and Liver Microsomes Results from Divergent Cytochrome P450 Activities.
    Bapiro TE; Martin S; Wilkinson SD; Orton AL; Hariparsad N; Harlfinger S; McGinnity DF
    Drug Metab Dispos; 2023 Jul; 51(7):892-901. PubMed ID: 37041083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks.
    Wagmann L; Brandt SD; Kavanagh PV; Maurer HH; Meyer MR
    Toxicol Lett; 2017 Apr; 272():84-93. PubMed ID: 28302559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase B oxidizes a novel multikinase inhibitor KW-2449 to its iminium ion and aldehyde oxidase further converts it to the oxo-piperazine form in human.
    Hosogi J; Ohashi R; Maeda H; Tashiro S; Fuse E; Yamamoto Y; Kuwabara T
    Drug Metab Pharmacokinet; 2017 Oct; 32(5):255-264. PubMed ID: 28751116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
    Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
    Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and clinical pharmacokinetics of 2-methyl-n-(2'-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1'-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools.
    Sawant Basak A; Byon W; Tseng-Lovering E; Funk C; Wood L; Lin C; Delnomdedieu M; Verhoest P; Parikh V; Cox LM; Miller E; Gao H; Obach RS
    Xenobiotica; 2014 May; 44(5):438-54. PubMed ID: 24304147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of predicted intrinsic hepatic clearance of 30 pharmaceuticals in canine and feline liver microsomes.
    Visser M; Zaya MJ; Locuson CW; Boothe DM; Merritt DA
    Xenobiotica; 2019 Feb; 49(2):177-186. PubMed ID: 29405805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
    Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Translation of Substrate Intrinsic Clearance from Recombinant CYP1A1 to Humans.
    Di L
    AAPS J; 2023 Oct; 25(6):98. PubMed ID: 37798423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation.
    Izat N; Bolleddula J; Abbasi A; Cheruzel L; Jones RS; Moss D; Ortega-Muro F; Parmentier Y; Peterkin VC; Tian DD; Venkatakrishnan K; Zientek MA; Barber J; Houston JB; Galetin A; Scotcher D
    Drug Metab Dispos; 2023 Dec; 51(12):1591-1606. PubMed ID: 37751998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.